Combined Insulin-Sulfonylurea Therapy in Treatment of NIDDM
暂无分享,去创建一个
[1] R. Turner,et al. Effect of sulphonylurea on insulin secretion and glucose control in insulin-treated diabetics. , 1981, British medical journal.
[2] H. Simpson,et al. Combination of Insulin with Glipizide Increases Peripheral Glucose Disposal in Secondary Failure Type 2 Diabetic Patients , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[3] L. Groop,et al. Do Sulfonylureas Influence Hepatic Insulin Clearance? , 1988, Diabetes Care.
[4] G. Grodsky,et al. Pancreatic action of the sulfonylureas. , 1977, Federation proceedings.
[5] L. Groop,et al. The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes. , 1984, Acta endocrinologica.
[6] Rizza Ra. Combined sulfonylurea and insulin therapy in insulin-dependent diabetes: research or clinical practice? , 1985 .
[7] D. Schade,et al. Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial. , 1987, JAMA.
[8] L. Groop,et al. secondary Failure to Treatment with Oral Antidiabetic Agents in Non-insulin-dependent Diabetes , 1986, Diabetes Care.
[9] J. Goldman,et al. Effect of glyburide on metabolic control and insulin binding in insulin-dependent diabetes mellitus. , 1984, Diabetes care.
[10] N. Nurjhan,et al. Insulin Dose-Response Characteristics for Suppression of Glycerol Release and Conversion to Glucose in Humans , 1986, Diabetes.
[11] K. Osei,et al. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. , 1984, The American journal of medicine.
[12] G. Paolisso,et al. The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion. , 1987, Acta endocrinologica.
[13] R. Rizza. Combined Sulfonylurea and Insulin Therapy in Insulin-dependent Diabetes: Research or Clinical Practice? , 1985, Diabetes Care.
[14] G. Sachse,et al. [Combination therapy with insulin and sulfonylurea in secondary failure of sulfonylurea therapy]. , 1984, Deutsche medizinische Wochenschrift.
[15] L. Groop,et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.
[16] J. Ward. Management of non-insulin-dependent diabetes. , 1990, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[17] L. Groop,et al. Different Effects of Glyburide and Glipizide on Insulin Secretion and Hepatic Glucose Production in Normal and NIDDM Subjects , 1987, Diabetes.
[18] U. Kabadi. Adjuvant Therapy with Tolazamide and Insulin Improves Metabolic Control in Type I Diabetes Mellitus , 1985, Diabetes Care.
[19] G. Grunberger,et al. Sulfonylureas Do Not Affect Insulin Binding or Glycemic Control in Insulin-dependent Diabetics , 1982, Diabetes.
[20] A. Pontiroli,et al. Sulfonylureas Enhance In Vivo the Effectiveness of Insulin in Type 1 (Insulin Dependent) Diabetes Mellitus , 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[21] A. Scheen,et al. Decreased or Increased Insulin Metabolism After Glipizide in Type II Diabetes? , 1988, Diabetes Care.
[22] A. A. Silver,et al. The effects of chronic administration of tolbutamide (orinase) in aged diabetics. , 1957, Maryland state medical journal.
[23] B. Volk,et al. PHYSIOLOGICAL BASIS OF THE EFFECTIVENESS OF COMBINED INSULIN‐TOLBUTAMIDE THERAPY IN STABLE DIABETES * , 1959, Annals of the New York Academy of Sciences.
[24] L. Groop,et al. Treatment failures: A common problem in the management of patients with type II diabetes , 1983 .
[25] L. Groop,et al. Effect of Glyburide on Glycemic Control, Insulin Requirement, and Glucose Metabolism in Insulin-Treated Diabetic Patients , 1987, Diabetes.
[26] G. Reaven,et al. Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone. , 1985, Archives of internal medicine.
[27] R. DeFronzo,et al. Regulation of hepatic glucose metabolism in humans. , 1987, Diabetes/metabolism reviews.
[28] L. Groop,et al. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients. , 1985, Annals of clinical research.
[29] I. Mirsky,et al. Ineffectiveness of Sulfonylureas in Alloxan Diabetic Rats.∗ , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[30] E. Friedlander. Use of tolbutamide in insulin-resistant diabetes; report of a case. , 1957, The New England journal of medicine.
[31] B. Burke,et al. Improved diabetic control in insulin-dependent diabetics treated with insulin and glibenclamide. , 1984, Acta endocrinologica.
[32] M. Hooper,et al. Effects of Combined Insulin-Sulfonylurea Therapy in type II Patients , 1989, Diabetes Care.
[33] L. Groop,et al. Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy. , 1989, The American journal of medicine.
[34] J. Assal,et al. Sulfonylureas in insulin-dependent (type I) diabetes: evidence for an extrapancreatic effect in vivo. , 1985, The Journal of clinical endocrinology and metabolism.
[35] F. Gries,et al. Management of Non‐insulin‐dependent Diabetes Mellitus in Europe: A Concensus View , 1988, Diabetic medicine : a journal of the British Diabetic Association.
[36] D. Garrel,et al. Acute effect of glyburide on insulin sensitivity in type I diabetic patients. , 1987, The Journal of clinical endocrinology and metabolism.
[37] O. Owen,et al. Insulin and a sulfonylurea agent in non-insulin-dependent diabetes mellitus. , 1986, Archives of internal medicine.
[38] K. Schöffling,et al. [Glibenclamide-insulin combination in the management of secondary failure of sulfonyl-urea medication]. , 2008, Deutsche medizinische Wochenschrift.
[39] J. Ketelslegers,et al. Effect of glibenclamide in insulin-treated diabetic patients with a residual insulin secretion. , 1986, Diabete & metabolisme.
[40] L. Groop,et al. Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone. , 2009, Acta medica Scandinavica.
[41] E. Haupt,et al. [Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides (author's transl)]. , 1977, Medizinische Klinik.
[42] H. Lebovitz,et al. Appraisal of the extrapancreatic actions of sulfonylureas. , 1969, Archives of internal medicine.
[43] M. Riddle,et al. Which Patients Might Benefit from Combining a Sulfonylurea with Insulin? , 1985, Diabetes Care.
[44] S. Efendić,et al. Glyburide Decreases Insulin Requirement, Increases (β-Cell Response to Mixed Meal, and Does Not Affect Insulin Sensitivity: Effects of Short- and Long-Term Combined Treatment in Secondary Failure to Sulfonylurea , 1987, Diabetes Care.
[45] R. Stout. Overview of the association between insulin and atherosclerosis. , 1985, Metabolism: clinical and experimental.
[46] M. Riddle. NEW TACTICS FOR TYPE 2 DIABETES: REGIMENS BASED ON INTERMEDIATE-ACTING INSULIN TAKEN AT BEDTIME , 1985, The Lancet.